‘Food Pharmacies’ In Clinics: When The Diagnosis Is Chronic Hunger

There’s a new question that anti-hunger advocates want doctors and nurses to ask patients: Do you have enough food?

Public health officials say the answer often is “not really.” So clinics and hospitals have begun stocking their own food pantries in recent years.

One of the latest additions is Connectus Health, a federally qualified health clinic in Nashville, Tenn. This month, part of LaShika Taylor’s office transformed into a community cupboard.

“It’s a lot of nonperishables right now, just because we’re just starting out,” she said, but the clinic is working on refrigeration so it can also stock fresh food.

Wildfire, Floods, Extreme Heat: California Prepares For Climate Change

While the U.S. has moved away from the landmark Paris Agreement on climate change, the state of California has dug in. Alongside New York and Washington, it created the United States Climate Alliance, a coalition looking to uphold the agreement through state actions. It’s also fighting with the Trump administration over the state’s long-standing restrictions on car emissions, which traditionally have been more stringent than federal standards.

Correvio’s heart drug fails to win FDA panel backing

(Reuters) – Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp’s drug to correct irregular rhythm in the upper chambers of the heart in adult patients.

The panel voted 11-2 against approval of the drug, Brinavess, citing serious safety risks.

Brinavess, currently available in 41 countries including the European Union and Canada, aims to restore normal heart rhythm in patients experiencing erratic rhythm due to a condition known as atrial fibrillation, or AFib.

The FDA is slated to announce a final decision by Dec. 24. It is not mandated to follow the recommendation of the panel, but generally does.

U.S. Supreme Court justices lean toward insurers on $12 billion Obamacare claims

WASHINGTON (Reuters) – U.S. Supreme Court justices on Tuesday appeared sympathetic to claims made by health insurers seeking $12 billion from the federal government under a program set up by the Obamacare law aimed at encouraging them to offer medical coverage to previously uninsured Americans.

FILE PHOTO: Demonstrators in favor of Obamacare gather at the Supreme Court building in Washington March 4, 2015. REUTERS/Jonathan Ernst/File Photo

The justices considered a challenge by a group of insurers of a lower court’s ruling that Congress had suspended the government’s obligation to make such payments. The insurers have said that ruling constituted a “bait-and-switch” that would enable the government to withhold money the companies were promised.

New Results for Experimental Alzheimer’s Drug

Latest Alzheimer’s News

FRIDAY, Dec. 6, 2019 (HealthDay News) — New study results about an experimental drug its maker claims can slow mental decline in Alzheimer’s disease patients were released Thursday.

Studies on aducanumab were halted earlier this year because the drug didn’t appear to be effective. But the new results suggest it’s effective at a high dose, the Associated Press reported.

The findings were presented at an Alzheimer’s conference in San Diego.

However, some experts say that changes during the study and unusual analyses make the results difficult to interpret and the risks and benefits of the drug unclear, the AP reported.

It’s Not Just You: Picking Health Insurance Is Hard. Here’s How To Be Smart About It.

Science has proved, no kidding around: Picking health insurance is extremely hard.

France to ban dozens of glyphosate weedkillers amid health risk debate

PARIS (Reuters) – France’s health and environment agency said on Monday it was banning dozens of glyphosate-based weedkillers, most of the volume of such products sold in France, ruling there was insufficient data to exclude health risks.

The ANSES agency was withdrawing the marketing license for 36 products which would no longer be authorized for use after the end of next year, it said in a statement.

The products accounted for nearly three-quarters of the volume of glyphosate products sold last year in France, the European Union’s biggest agricultural producer, it said.

Austrian leader blocks ban on weedkiller glyphosate, citing technicality

VIENNA (Reuters) – Austria’s caretaker leader on Monday made clear she would not sign into law the European Union’s first national ban on the weedkiller glyphosate due to a technicality, infuriating environmentalists while delighting farmers’ groups.

A large majority in parliament and, polls suggest, the public support banning the chemical because of fears it causes cancer. Austria, a popular tourist destination for its Alpine landscapes, also devotes the largest share of its farmland to organic agriculture of any EU member state.

In July, when the current caretaker government of civil servants was already in place, parliament passed the total ban, which was due to come into force on Jan. 1.

Black Mothers Get Less Treatment For Postpartum Depression Than Other Moms

Portia Smith’s most vivid memories of her daughter’s first year are of tears. Not the baby’s. Her own.

“I would just hold her and cry all day,” Smith said.

At 18, Smith was caring for two children, 4-year-old Kelaiah and newborn Nelly, with little help from the partner in her abusive relationship. The circumstances were difficult, but she knew the tears were more than that.

“I really didn’t have a connection for her,” said Smith, now a motivational speaker and mother of three living in Philadelphia. “I didn’t even want to breastfeed because I didn’t want that closeness with her.”